title: Response: Co-administration of cyclosporine A and imatinib among patients with Philadelphia chromosome-positive leukemias in the post-transplant setting.
authors: Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.
authors: Ferdows
authors: F
authors: Atiq
authors: Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands.
authors: Annoek E C
authors: AE
authors: Broers
authors: Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.
authors: Louise M
authors: LM
authors: Andrews
authors: Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands.
authors: Jeanette K
authors: JK
authors: Doorduijn
authors: Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.
authors: Birgit C P
authors: BC
authors: Koch
authors: Department of Hospital Pharmacy, Erasmus Medical Center, Rotterdam, The Netherlands.|Department of Internal Medicine, Erasmus Medical Center, PO Box 2040, 3000, CA, Rotterdam, The Netherlands.
authors: Teun
authors: T
authors: Van Gelder
authors: Department of Internal Medicine, Erasmus Medical Center, PO Box 2040, 3000, CA, Rotterdam, The Netherlands. J.versmissen@erasmusmc.nl.
authors: Jorie
authors: J
authors: Versmissen
mesh_terms: D000970:Antineoplastic Agents; D001549:Benzamides; D016572:Cyclosporine; D006801:Humans; D000068877:Imatinib Mesylate; D007938:Leukemia; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive; D010677:Philadelphia Chromosome; D010879:Piperazines; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma; D011743:Pyrimidines
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D016572:Cyclosporine; D000068877:Imatinib Mesylate